HSPG2 and lung cancer: Franses and colleagues explored the role of endothelial cells in regulating cancer cell behavior, where perlecan silencing eliminated the ability of endothelial cells to suppress cancer invasiveness in both in vitro and in vivo models of breast and lung cancer (75).